WallStreetZenWallStreetZen

NASDAQ: GILD
Gilead Sciences Inc Earnings & Revenue

GILD past earnings growth

How has GILD's earnings growth performed historically?
Company
-91.03%
Industry
19%
Market
119.55%
GILD's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
GILD's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
GILD's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

GILD past revenue growth

How has GILD's revenue growth performed historically?
Company
1.51%
Industry
9.22%
Market
15.78%
GILD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
GILD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
GILD's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

GILD earnings and revenue history

Current Revenue
$27.5B
Current Earnings
$484.0M
Current Profit Margin
1.8%
GILD's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

GILD Return on Equity

Current Company
2.3%
Current Industry
34.9%
Current Market
28.2%
GILD's Return on Equity (2.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when GILD announces earnings.

GILD Return on Assets

Current Company
0.8%
Current Industry
8.2%
GILD is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

GILD Return on Capital Employed

Current Company
4.78%
Current Industry
14.4%
GILD's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

GILD vs General Drug Manufacturer Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
GILD$27.45B$4.81B$484.00M+4.22%-38.59%
BMY$45.53B$4.00B-$6.15B+14.35%N/A
GSK$37.95B$7.29B$5.54B-1.11%+1.40%
SNY$49.94B$14.09B$5.81B+4.70%+3.84%
BIIB$9.66B$1.85B$1.17B-6.89%-19.14%

GILD earnings dates

Next earnings date
Jun 12, 2024

Gilead Sciences Earnings & Revenue FAQ

What were GILD's earnings last quarter?

On Invalid Date, Gilead Sciences (NASDAQ: GILD) reported Q1 2024 earnings per share (EPS) of -$3.34, up 512.35% year over year. Total Gilead Sciences earnings for the quarter were -$4.17 billion. In the same quarter last year, Gilead Sciences's earnings per share (EPS) was $0.81.

If you're new to stock investing, here's how to buy Gilead Sciences stock.

What was GILD's earnings growth in the past year?

As of Q2 2024, Gilead Sciences's earnings has grown -91.03% year over year. This is 110.03 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 19%. Gilead Sciences's earnings in the past year totalled $484.00 million.

What is GILD's earnings date?

Gilead Sciences's earnings date is Invalid Date. Add GILD to your watchlist to be reminded of GILD's next earnings announcement.

What was GILD's revenue last quarter?

On Invalid Date, Gilead Sciences (NASDAQ: GILD) reported Q1 2024 revenue of $6.69 billion up 5.26% year over year. In the same quarter last year, Gilead Sciences's revenue was $6.35 billion.

What was GILD's revenue growth in the past year?

As of Q2 2024, Gilead Sciences's revenue has grown 1.51% year over year. This is 7.72 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 9.22%. Gilead Sciences's revenue in the past year totalled $27.45 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.